COVID-19 and atrial fibrillation: Intercepting lines

M Donniacuo, A De Angelis, C Rafaniello… - Frontiers in …, 2023 - frontiersin.org
Almost 20% of COVID-19 patients have a history of atrial fibrillation (AF), but also a new-
onset AF represents a frequent complication in COVID-19. Clinical evidence demonstrates …

Cardiovascular Complications of Interatrial Conduction Block: JACC State-of-the-Art Review

DA Power, J Lampert, A Camaj, SW Bienstock… - Journal of the American …, 2022 - jacc.org
Interatrial block (IAB) is an electrocardiographic pattern describing the conduction delay
between the right and left atria. IAB is classified into 3 degrees of block that correspond to …

Assessment of Left Atrial Fibrosis by Cardiac Magnetic Resonance Imaging in Ischemic Stroke Patients Without Atrial Fibrillation: A Systematic Review and Meta …

JH Koh, LKE Lim, YK Tan, C Goh, YH Teo… - Journal of the …, 2024 - ahajournals.org
Background Left atrial (LA) fibrosis is a marker of atrial cardiomyopathy and has been
reported to be associated with both atrial fibrillation and ischemic stroke. Elucidating this …

Prediction of underlying atrial fibrillation in patients with a cryptogenic stroke: results from the NOR-FIB Study

B Ratajczak-Tretel, AT Lambert, R Al-Ani, K Arntzen… - Journal of …, 2023 - Springer
Background Atrial fibrillation (AF) detection and treatment are key elements to reduce
recurrence risk in cryptogenic stroke (CS) with underlying arrhythmia. The purpose of the …

Coronary microvascular dysfunction and hypertension: a bond more important than we think

M Zdravkovic, V Popadic, S Klasnja, A Klasnja… - Medicina, 2023 - mdpi.com
Coronary microvascular dysfunction (CMD) is a clinical entity linked with various risk factors
that significantly affect cardiac morbidity and mortality. Hypertension, one of the most …

Patchy fibrosis promotes trigger–substrate interactions that both generate and maintain atrial fibrillation

MA Colman, R Sharma, OV Aslanidi… - Interface …, 2023 - royalsocietypublishing.org
Fibrosis has been mechanistically linked to arrhythmogenesis in multiple cardiovascular
conditions, including atrial fibrillation (AF). Previous studies have demonstrated that fibrosis …

Stroke in atrial fibrillation and other atrial dysrhythmias

H Ozdemir, D Sagris, GYH Lip… - Current Cardiology …, 2023 - Springer
Abstract Purpose of Review Atrial fibrillation (AF) is a major risk factor for systemic embolism
and ischaemic stroke. Furthermore, AF-related strokes are associated with higher mortality …

Targeting the Substrate for Atrial Fibrillation: JACC Review Topic of the Week

MD McCauley, G Iacobellis, N Li, S Nattel… - Journal of the American …, 2024 - jacc.org
The identification of the pulmonary veins as a trigger source for atrial fibrillation (AF) has
established pulmonary vein isolation (PVI) as a key target for AF ablation. However, PVI …

[HTML][HTML] Irisin attenuates angiotensin II-induced atrial fibrillation and atrial fibrosis via LOXL2 and TGFβ1/Smad2/3 signaling pathways

Y Wu, J Luo, X Song, W Gu, S Wang… - Iranian Journal of …, 2023 - ncbi.nlm.nih.gov
Objective (s): Irisin was reported as a cardioprotective and anti-oxidative effector, while the
effect on atrial fibrosis is unknown. The current research examined irisin's function in atrial …

A simple score to predict new-onset atrial fibrillation after ablation of typical atrial flutter

Z Gu, J Jiao, Y Shen, X Ding, C Zhu, M Li… - Canadian Journal of …, 2024 - Elsevier
Background New-onset atrial fibrillation (NeAF) is common after cavotricuspid isthmus-
dependent counterclockwise atrial flutter (CCW-AFL) ablation. This study aimed to …